简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Digital Health Acquisition Corp. (NASDAQ:DHACW) Short Interest Down 60.0% in August

2022-08-29 12:12

Digital Health Acquisition Corp. (NASDAQ:DHACW – Get Rating) was the recipient of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 200 shares, a decrease of 60.0% from the July 31st total of 500 shares. Based on an average daily volume of 39,100 shares, the days-to-cover ratio is presently 0.0 days.

Digital Health Acquisition Stock Up 11.3 %

DHACW traded up $0.01 on Friday, reaching $0.14. The company's stock had a trading volume of 62,805 shares, compared to its average volume of 63,000. The business has a 50 day simple moving average of $0.09. Digital Health Acquisition has a fifty-two week low of $0.02 and a fifty-two week high of $0.45.

Get Digital Health Acquisition alerts:

Digital Health Acquisition Company Profile

(Get Rating)

Digital Health Acquisition Corp. focuses on entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on technology and healthcare focused businesses. The company was incorporated in 2021 and is based in Boca Raton, Florida.

See Also

  • Get a free copy of the StockNews.com research report on Digital Health Acquisition (DHACW)
  • Why This Dip in Advanced Auto Parts May be an Opportunity
  • MarketBeat: Week in Review 8/22 – 8/26
  • Institutional Buying Put A Bottom In Marvell Technology
  • Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory
  • 3 Reasons Dollar General's Rally Has Legs

Receive News & Ratings for Digital Health Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digital Health Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。